FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000UL6Q8X0

Market Closed - Deutsche Boerse AG 18:27:43 31/05/2024 BST
7.08 EUR -5.73% Intraday chart for FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month-13.13%
1 month-13.13%
Date Price Change
31/05/24 7.08 -5.73%
30/05/24 7.51 -2.09%
29/05/24 7.67 -.--%
28/05/24 7.67 +11.48%
27/05/24 6.88 -1.71%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 06:27 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer UBS
WKN UL6Q8X
ISINDE000UL6Q8X0
Date issued 25/07/2023
Strike 181.6 $
Maturity Unlimited
Parity 4.39 : 1
Emission price 4.98
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 9.01
Lowest since issue 4.35
Spread 0.2
Spread %2.68%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146.7 USD
Average target price
171.9 USD
Spread / Average Target
+17.23%
Consensus